DEFINITION

Scaffold Human Amniotic Membrane Allograft is derived from normal human placental amniotic tissue obtained from full-term pregnancies. The amniotic tissue is isolated and decellularized to remove cellular contaminants, resulting in an extracellular matrix with basement membrane. Scaffold Human Amniotic Membrane Allograft is composed predominantly of collagen and elastin. Tissues are obtained from sources that have passed applicable donor tissue eligibility requirements for relevant diseases, are processed, dehydrated, and terminally sterilized with e-beam irradiation. Scaffold Human Amniotic Membrane Allograft is supplied in a dry sheet form and is stored at ambient temperature.